Editorial Perspectives On Decentralized Trials

51. Online Recruitment & A Virtual Study Net 4,000 Participants For MAGENTA Trial 8/27/2020

    Stand Up To Cancer (SU2C) has been around for more than 10 years. The organization was founded to promote collaborative and innovative cancer research by bringing together the best and brightest minds in the industry. It's recent MAGENTA study recruited nearly 4,000 patients by using online tools and a virtual approach.

52. How TissueTech Managed Growth, Virtual Trials, And Survived COVID-19 8/11/2020

    Since its inception in 1997, TissueTech has been a pioneer in the clinical application of human birth tissues. In July 2020 the company announced the initiation of the first of two Phase 3 clinical trials. To complete those trials, the company knew it had to grow its internal capabilities. It did so by investing heavily in the expansion of its clinical and manufacturing programs.

53. Industry Execs Expect Continued Growth In mHealth & Virtual Trials 7/30/2020

    Research firm Industry Standard Research recently asked 329 respondents from sponsor organizations to share their thoughts about a variety of current trends in the clinical development space. ISR analyzed responses by company size to understand how perspectives of respondents at large sponsors differ from those at non-large organizations.

54. BMS Uses Virtual Technology To Empower Patient Communities 7/28/2020

    Patient centricity continues to play a pivotal role in how healthcare companies design and build clinical trials. The drive to get the patient voice involved in trial design has resulted in more companies interacting with patients and patient advocacy groups.

55. ADAPTABLE Study Shows The Potential Of Virtual Trials 7/21/2020

    DCRI and PCORI started the ADAPTABLE clinical trial to the effect of different aspirin doses on patients with heart disease. Now that the trial is winding down, it's success has also shown sponsor companies how to successfully navigate a large, virtual clinical trial.

56. COVID-19 & The Virtual Trial Rush: Front-Line Insights 5/19/2020

    The COVID-19 pandemic caught many sponsor companies and sites unprepared. Clinical trial participants were told to stay home for their own safety and to relieve the burden on site personnel. For companies that had millions invested in trials that required data from those patients, panic set in and the rush was on for new technology solutions.

57. Despite COVID-19, Patients Are Interested In New Trials 4/14/2020

    Patient-recruitment company SubjectWell connected with sites and patients to learn how the uncertainty of the COVID-19 pandemic is impacting sites and the feelings of patients regarding their participation in clinical trials.

58. COVID-19 And Its Impact On Clinical Trials 4/10/2020

    Debora Araujo, founder and CEO of ClinBiz, recently hosted a live online discussion on the COVID-19 pandemic and the impact it will have on clinical trials. The purpose of the call was to share knowledge of how the pandemic might impact clinical trials and what sponsor companies can do to adapt. 

59. Amid COVID-19, Clinical Trials Must Go On 4/8/2020

    The COVID-19 pandemic continues to impact economies around the world, and many businesses and activities have been curtailed or shut down. Others, however, must continue to move forward. Clinical trials fall into the latter category.

60. Covid-19 Hastens Embrace Of Virtual Trials 3/30/2020

    The COVID-19 pandemic is making clinical trials difficult for sponsors, sites, and patients. But will the changes needed to protect patients finally make virtual trials a reality?